• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      Ape-directory
      AVCJ Private Equity Online Directory

      With its wide network of senior industry contacts, the directory is the most comprehensive online directory on private equity and venture capital in Asia. It is easy to navigate, enabling access to Asian private equity firms and professionals.

      Read more
      2016-china-cover
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Renminbi fund

renminbi-note-man-china
River Head Capital hits first close on latest reminbi fund

China’s River Head Capital has achieved a first close on its second Innovation Growth Fund, a renminbi-denominated vehicle that has an overall target of CNY 2bn (USD 135m).

  • Greater China
  • 24 January 2022
usd-rmb-dollar-renminbi
Eastern Bell raises $2b across US dollar, renminbi funds

Eastern Bell Capital has closed its second US dollar-denominated fund and its sixth renminbi-denominated fund with aggregate commitments of more than CNY 13bn (USD 2bn).

  • Greater China
  • 04 January 2022
dollar-notes-eye-view-telescope
Legend hits first close on healthcare fund, launches TMT vehicle

Legend Capital has reached a first close of $177 million on its third US dollar-denominated China healthcare fund. It is one of five vehicles the GP has in the market, including its recently launched ninth flagship technology, media, and telecom (TMT)...

  • Greater China
  • 29 November 2021
dollar-rmb-hidden
Cross-currency restructuring underpins Ameba's VC fund

China-focused VC firm Ameba Capital has closed its debut US dollar-denominated fund at $265 million, supported by a renminbi-to-US dollar secondary restructuring and a primary staple.

  • Greater China
  • 04 November 2021
cao-yi-2021-pic-5
China's Source Code raises $1.1b renminbi fund

Chinese venture capital firm Source Code Capital has raised RMB7 billion ($1.1 billion) for its fifth renminbi-denominated fund after approximately three months in the market.

  • Greater China
  • 11 October 2021
rules-regulations-stamp-papers
China promises clampdown on illegal PE fundraising

China’s securities regulator has pledged to crack down on illegal domestic private equity fundraising, specifically products that managers claim are aimed at qualified investors but they in fact distribute to the retail market.

  • Greater China
  • 03 September 2021
rmb-china-hands
China's Oceanpine raises $312m for renminbi hard-tech fund

Chinese technology and healthcare investor Oceanpine Capital has closed its Hardcore Technology Investment Fund on RMB2 billion ($312 million). LPs include government guidance funds and fund-of-funds in Suzhou, where the new vehicle is based.

  • Greater China
  • 04 June 2021
usd-rmb-dollar-renminbi
China's Yingke closes renminbi, US dollar funds

Shanghai-based Yingke Private Equity has raised RMB10 billion ($1.57 billion) for its latest renminbi-denominated fund as well as an undisclosed sum for a third US dollar vehicle.

  • Greater China
  • 31 May 2021
rules-regulations-stamp-papers
Shanghai broadens investment scope of QFLP

Shanghai is giving foreign investors better access to unlisted assets and private funds - under an expanded Qualified Foreign Limited Partner (QFLP) regime - as part of efforts to establish itself as a global asset management hub.

  • Greater China
  • 27 May 2021
renminbi-businessman
China's Meridian raises $330m for renminbi fund

Chinese VC firm Meridian Capital has closed its sixth renminbi-denominated fund at RMB2.12 billion ($330 million) after four months in the market.

  • Greater China
  • 21 May 2021
rmb-china-hands
China distress specialist DCL targets $466m fundraise

DCL Investments, one of China’s first private equity firms to focus on distressed assets, is looking to raise RMB3 billion ($466 million) for its latest renminbi-denominated fund.

  • Greater China
  • 18 May 2021
xiaosong-liu-qingsong
Fund focus: Qingsong plays the long game

Qingsong Fund differs from most renminbi fund managers by virtue of its uncommon diversification and farsighted strategy. Data and deep tech will be key focus areas for the firm’s new $153 million fund

  • Greater China
  • 14 April 2021
usd-rmb-dollar-renminbi
5Y raises $2b across dollar, renminbi funds

China's 5Y Capital has raised nearly $2 billion for its latest US dollar and renminbi-denominated funds, securing $1.7 billion for the US dollar pool and around RMB1.9 billion ($290 million) for the local currency vehicle.

  • Greater China
  • 13 April 2021
venture-youth-hands-plant-early-stage
Qingsong raises $153m for fourth China VC fund

Qingsong Fund, a Chinese venture capital firm formed by Xiaosong Liu, an angel investor and co-founder of Tencent Holdings, has closed its fourth renminbi-denominated fund with RMB1 billion ($153 million).

  • Greater China
  • 01 April 2021
renminbi-rmb-dollar-notes
PE topples advisory as China Renaissance's key business

Fund management has become China Renaissance’s largest source of revenue, seven years after the firm – best known for providing private placement and M&A advisory services to Chinese internet companies – entered the private equity business.

  • Greater China
  • 28 March 2021
biotech-healthcare-life-science-drug
Addor raises $241m for second China healthcare fund

Addor Capital – a Chinese VC firm backed by Jiangsu High-Tech Investment Group, also known as Govtor Capital – has raised RMB1.56 billion ($241 million) for its second renminbi-denominated healthcare fund.

  • Greater China
  • 05 March 2021
venture-youth-hands-plant-early-stage
China VCs back See Fund's debut vehicle

See Fund, an investment firm established by the founder of Chinese artificial intelligence chip start-up DeePhi Technology, has raised RMB200 million ($31 million) for its debut fund.

  • Greater China
  • 03 March 2021
renminbi-sky-fly-bird-china
China's Fresh Capital hits $93m first close on Fund II

Fresh Capital, a Shanghai-based venture capital firm, has reached a first close of RMB600 million ($93 million) on its second renminbi-denominated fund.

  • Greater China
  • 25 February 2021
ggv-team
GGV closes latest US dollar funds at $2.5b

GGV Capital has closed its latest set of US dollar-denominated funds with $2.52 billion in aggregate commitments. It represents the largest fundraising since the firm’s inception in 2000.

  • Greater China
  • 28 January 2021
rmb-funds
Qiming raises $441m for its sixth renminbi fund

Qiming Venture Partners has closed its sixth renminbi-denominate vehicle at RMB2.85 billion ($441 million), taking the firm's total assets under management to $5.9 billion.

  • Greater China
  • 26 January 2021
xiaodan-liu-firstred
Fund focus: Firstred's advisory angle

Firstred Capital has already completed six deals from its debut fund, making commitments that are flexible in structure to Chinese companies that need its M&A expertise

  • Greater China
  • 22 January 2021
renminbi-note-man-china
China's Firstred closes debut renminbi fund on $1b

Firstred Capital, a Chinese growth and buyout investor in healthcare, consumer products and services, and industrial technology, has closed its debut fund with RMB6.8 billion ($1 billion) in commitments.

  • Fundraising
  • 11 January 2021
DCL
Fund focus: DCL targets China's unremitting debtors

With $455 million in commitments for its latest renminbi fund, DCL Investments hopes to make its on-the-ground capabilities count in resolving China’s non-performing loans problem

  • Greater China
  • 09 December 2020
orthopedic-orthopedist
Deal focus: Huaxing gives overseas LPs taste of China medtech

In addition to raising $213 million for its latest renminbi-denominated fund, Huaxing Healthcare Capital sourced $230 million from co-investors for a succession deal in China’s orthopedics space

  • Greater China
  • 04 December 2020
1 2 3

Most read

healthcare-pharma-lab-drug-biotech
Co-Stone leads $43m round for China biosynthesis player
healthcare-medical-app
Australia’s Heal Partners closes debut fund on $137m
zhihu-ipo
US regulator gets access to Chinese audits
avcj-221215cvr-72
Weekly digest - December 15 2022
nbfc-loan-mortgage
TPG buys India's Poonawalla Housing Finance
  • About AVCJ
  • Advertise
  • Contacts
  • About Acuris
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013